只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-20 2026-07-22 | CLBK Columbia Financial, Inc./MD/ | Gibney Dennis E. Director,Officer · 1st Sr. EVP, CBO | 买入（P） | 20,500 | US$10.00 | US$205,000.00 | 376,592 | SEC |
| 2026-07-20 2026-07-22 | CLBK Columbia Financial, Inc./MD/ | Gibney Dennis E. Director,Officer · 1st Sr. EVP, CBO | 买入（P） | 12,500 | US$10.00 | US$125,000.00 | 34,500 | SEC |
| 2026-07-20 2026-07-22 | CLBK Columbia Financial, Inc./MD/ | Gibney Dennis E. Director,Officer · 1st Sr. EVP, CBO | 买入（P） | 11,500 | US$10.00 | US$115,000.00 | 11,500 | SEC |
| 2026-07-17 2026-07-20 | ESNT Essent Group Ltd. | Gibbons Mary Lourdes Officer · SVP and Chief Legal Officer | 卖出（S） | 4,678 | US$67.04 | US$313,613.12 | 228,658 | SEC |
| 2026-07-13 2026-07-15 | KBH KB HOME | McGibney Robert V. Director,Officer · President and CEO | 卖出（S） | 20,621 | US$55.31 | US$114.05万 | 188,705 | SEC |
| 2026-06-16 2026-06-16 | AURA Aura Biosciences, Inc. | Gibney Anthony S Officer · See Remarks | 卖出（S） | 12,824 | US$6.42 | US$82,330.08 | 265,354 | SEC |
| 2026-06-09 2026-06-10 | WAL WESTERN ALLIANCE BANCORPORATION | GIBBONS DALE Officer · Vice Chair and CBO, Deposits | 卖出（S） | 33,228 | US$82.64 | US$274.6万 | 273,865 | SEC |
| 2026-06-09 2026-06-10 | WAL WESTERN ALLIANCE BANCORPORATION | GIBBONS DALE Officer · Vice Chair and CBO, Deposits | 卖出（S） | 6,772 | US$81.16 | US$549,615.52 | 267,093 | SEC |
| 2026-06-05 2026-06-05 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher Director | 卖出（S） | 40,000 | US$3.62 | US$144,800.00 | 883,735 | SEC |
| 2026-05-26 2026-05-27 | ROCK GIBRALTAR INDUSTRIES, INC. | Bosway William T Director,Officer · President and CEO | 买入（P） | 19,735 | US$37.44 | US$738,878.40 | 250,320 | SEC |
| 2026-05-22 2026-05-27 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher Director | 卖出（S） | 40,000 | US$3.08 | US$123,200.00 | 883,735 | SEC |
| 2026-05-21 2026-05-22 | ROCK GIBRALTAR INDUSTRIES, INC. | Bolanowski Katherine Officer · General Counsel, VP, Secretary | 买入（P） | 144 | US$35.66 | US$5,135.04 | 17,389 | SEC |
| 2026-05-21 2026-05-22 | ROCK GIBRALTAR INDUSTRIES, INC. | Bolanowski Katherine Officer · General Counsel, VP, Secretary | 买入（P） | 1,256 | US$35.63 | US$44,751.28 | 17,245 | SEC |
| 2026-05-20 2026-05-21 | ROCK GIBRALTAR INDUSTRIES, INC. | Lovechio Joseph A Officer · VP and CFO | 买入（P） | 1,000 | US$34.62 | US$34,620.00 | 13,390 | SEC |
| 2026-05-07 2026-05-08 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher Director | 卖出（S） | 40,000 | US$3.37 | US$134,800.00 | 926,556 | SEC |
| 2026-04-28 2026-04-30 | ESNT Essent Group Ltd. | Gibbons Mary Lourdes Officer · SVP and Chief Legal Officer | 卖出（S） | 4,250 | US$65.01 | US$276,292.50 | 233,336 | SEC |
| 2026-04-22 2026-04-24 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher Director | 卖出（S） | 40,000 | US$3.61 | US$144,400.00 | 906,556 | SEC |
| 2026-04-20 2026-04-21 | ESNT Essent Group Ltd. | Gibbons Mary Lourdes Officer · SVP and Chief Legal Officer | 卖出（S） | 7,628 | US$63.01 | US$480,640.28 | 237,586 | SEC |
| 2026-04-17 2026-04-21 | ESNT Essent Group Ltd. | Gibbons Mary Lourdes Officer · SVP and Chief Legal Officer | 卖出（S） | 872 | US$63.00 | US$54,936.00 | 245,214 | SEC |
| 2026-04-07 2026-04-08 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher Director | 卖出（S） | 40,000 | US$3.10 | US$124,000.00 | 906,556 | SEC |
| 2026-04-06 2026-04-06 | AFYA Afya Ltd | Gibbon Virgilio Deloy Capobianco Officer · Chief Executive Officer | 卖出（S） | 770 | US$14.91 | US$11,480.70 | 108,448 | SEC |
| 2026-04-02 2026-04-06 | AFYA Afya Ltd | Gibbon Virgilio Deloy Capobianco Officer · Chief Executive Officer | 卖出（S） | 20,900 | US$14.94 | US$312,246.00 | 109,218 | SEC |
| 2026-04-01 2026-04-03 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Gibson James R II Officer · See Remarks | 卖出（S） | 88,185 | US$1.37 | US$120,813.45 | 1,245,663 | SEC |
| 2026-04-01 2026-04-02 | AFYA Afya Ltd | Gibbon Virgilio Deloy Capobianco Officer · Chief Executive Officer | 卖出（S） | 19,500 | US$14.98 | US$292,110.00 | 130,118 | SEC |
| 2026-03-31 2026-04-02 | AFYA Afya Ltd | Gibbon Virgilio Deloy Capobianco Officer · Chief Executive Officer | 卖出（S） | 2,320 | US$14.92 | US$34,614.40 | 149,618 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| CGIB | 531,391 | 0 | 561,701.5585 | 94.60% | Q |
| GIB | 77,829.0991 | 0 | 110,992.4173 | 70.12% | B, Q, N |
| GIBO | 6,373 | 0 | 14,304.6394 | 44.55% | Q |
| IGIB | 424,099.0032 | 1 | 1,668,668.0436 | 25.42% | B, Q, N |